Eplerenone API Market Size will reach to 23.0 mt in 2024

    Eplerenone belongs to diuretics drugs of hypertension treatment. It can be used alone or in combination with other drugs to treat hypertension. Eplerenone also can be used to treat congestive heart failure after acute myocardial infarction. It is first marketed by Pfizer with brand Inspra in 2002. Eplerenone API is used to produce eplerenone tablet.

    The key starting raw materials of Eplerenone is 11α-Hydroxycarvenone which is used to produce 11α-Hydroxy canrenone methacrylate which is a key Intermediate of Eplerenone.

    This report cover the Eplerenone industrial chain based on API. Following are the industrial chain structure:

Source: HDIN Research

    Global diuretics drugs of hypertension treatment market size is 11.1 billion USD in 2018. The Eplerenone market size increase to 440 million USD in 2018 with 8.9% CAGR from 2014. The Eplerenone’s market share is 4% according IMS data. Global Eplerenone API market volume was estimated at 19.8 mt in 2018 and is forecasted to reach 23.0 mt in 2024, with a CAGR of 2.5% according to HDIN Research data.

Source: HDIN Research

    There are 6 Eplerenone API producers investigated in the report including MSN, Industriale Chimica, Zhejiang Xianju Yangguang Bioproducts, Aurisco Pharmaceutical etc. The report also investigate end user of Eplerenone API such as Pfizer, APOTEX, Mylan etc.